Healthcare & Life Sciences
Nocion Therapeutics
United Stateswww.nociontx.com
Nocion Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series B, 2 tracked investors.
Activeseries-b
series-b
Stage
2
Investors
About Nocion Therapeutics
Nocion Therapeutics is a startup based in the United States. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Nocion Therapeutics develops charged small-molecule sodium-channel blockers called nocions that selectively silence activated sensory neurons to treat conditions such as chronic cough, itch, and pain. Their lead program, Taplucainium, is in a global Phase 2b clinical trial for refractory chronic cough.
Explore Nocion Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.